KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $133.39 $156.84 Friday, 26th Apr 2024 ASND stock ended at $135.90. This is 0.752% less than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 4.81% from a day low at $133.39 to a day high of $139.81.
90 days $128.67 $161.00
52 weeks $66.03 $161.00

Historical Ascendis Pharma A/S prices

Date Open High Low Close Volume
Apr 26, 2024 $137.00 $139.81 $133.39 $135.90 225 238
Apr 25, 2024 $140.59 $140.59 $136.19 $136.93 364 688
Apr 24, 2024 $144.00 $144.68 $141.06 $143.18 200 443
Apr 23, 2024 $143.30 $147.45 $143.30 $144.83 205 213
Apr 22, 2024 $140.48 $144.33 $140.48 $142.10 225 623
Apr 19, 2024 $141.39 $144.41 $137.78 $140.17 267 109
Apr 18, 2024 $143.00 $143.18 $140.23 $140.89 217 884
Apr 17, 2024 $142.80 $144.25 $140.80 $142.17 290 103
Apr 16, 2024 $144.53 $148.10 $141.05 $141.50 358 307
Apr 15, 2024 $145.64 $150.11 $145.00 $145.23 375 736
Apr 12, 2024 $151.14 $152.53 $144.36 $146.04 305 361
Apr 11, 2024 $153.85 $154.41 $150.91 $151.04 311 303
Apr 10, 2024 $151.50 $156.84 $151.50 $152.58 419 217
Apr 09, 2024 $149.74 $153.81 $148.30 $153.67 260 843
Apr 08, 2024 $150.97 $150.97 $147.56 $148.88 157 850
Apr 05, 2024 $147.93 $150.62 $145.44 $149.88 156 144
Apr 04, 2024 $150.99 $151.48 $146.60 $147.65 209 745
Apr 03, 2024 $146.45 $150.00 $144.02 $149.50 235 149
Apr 02, 2024 $150.50 $152.81 $146.26 $146.29 329 495
Apr 01, 2024 $151.07 $153.85 $149.34 $151.98 328 540
Mar 28, 2024 $149.15 $151.59 $144.66 $151.17 294 753
Mar 27, 2024 $150.16 $150.65 $146.93 $148.44 240 818
Mar 26, 2024 $145.56 $150.79 $144.96 $149.96 291 980
Mar 25, 2024 $145.73 $147.10 $144.05 $144.46 141 879
Mar 22, 2024 $147.03 $147.99 $144.22 $145.02 173 387
Click to get the best stock tips daily for free!

About Ascendis Pharma A/S

Ascendis Pharma A/S Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult hypoparathyroidism; and TransCon CNP for pediatric achondroplasia. In addition, the company develops Tra... ASND Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT